Previous studies suggested that BAY11‐7082 suppressed the NF‐κB activity in many types of cancers, including lung cancer, leukemic, prostate cancer and cervical cancer.36, 37, 38, 39. The gene discussed is NFKB1; the disease is lung carcinoma.